233 related articles for article (PubMed ID: 32766674)
1. Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging.
Rasmussen LJH; Caspi A; Ambler A; Danese A; Elliott M; Eugen-Olsen J; Hariri AR; Harrington H; Houts R; Poulton R; Ramrakha S; Sugden K; Williams B; Moffitt TE
J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(2):318-327. PubMed ID: 32766674
[TBL] [Abstract][Full Text] [Related]
2. Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.
Rasmussen LJH; Moffitt TE; Eugen-Olsen J; Belsky DW; Danese A; Harrington H; Houts RM; Poulton R; Sugden K; Williams B; Caspi A
J Child Psychol Psychiatry; 2019 Feb; 60(2):199-208. PubMed ID: 29741788
[TBL] [Abstract][Full Text] [Related]
3. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
Rasmussen LJH; Petersen JEV; Eugen-Olsen J
Front Immunol; 2021; 12():780641. PubMed ID: 34925360
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
Persson M; Engström G; Björkbacka H; Hedblad B
Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.
Törnkvist PBS; Haupt TH; Rasmussen LJH; Ladelund S; Toft U; Pisinger C; Eugen-Olsen J
Br J Nutr; 2019 Mar; 121(6):699-708. PubMed ID: 30626457
[TBL] [Abstract][Full Text] [Related]
7. Association of GDF15 With Inflammation and Physical Function During Aging and Recovery After Acute Hospitalization: A Longitudinal Study of Older Patients and Age-Matched Controls.
Tavenier J; Rasmussen LJH; Andersen AL; Houlind MB; Langkilde A; Andersen O; Petersen J; Nehlin JO
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):964-974. PubMed ID: 33428715
[TBL] [Abstract][Full Text] [Related]
8. Linking stressful life events and chronic inflammation using suPAR (soluble urokinase plasminogen activator receptor).
Bourassa KJ; Rasmussen LJH; Danese A; Eugen-Olsen J; Harrington H; Houts R; Poulton R; Ramrakha S; Sugden K; Williams B; Moffitt TE; Caspi A
Brain Behav Immun; 2021 Oct; 97():79-88. PubMed ID: 34224821
[TBL] [Abstract][Full Text] [Related]
9. Social isolation, loneliness, and inflammation: A multi-cohort investigation in early and mid-adulthood.
Matthews T; Rasmussen LJH; Ambler A; Danese A; Eugen-Olsen J; Fancourt D; Fisher HL; Iversen KK; Schultz M; Sugden K; Williams B; Caspi A; Moffitt TE
Brain Behav Immun; 2024 Jan; 115():727-736. PubMed ID: 37992788
[TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia.
Toldi G; Bíró E; Szalay B; Stenczer B; Molvarec A; Rigó J; Vásárhelyi B; Bekõ G
Clin Chem Lab Med; 2011 Nov; 49(11):1873-6. PubMed ID: 21722073
[TBL] [Abstract][Full Text] [Related]
11. Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor.
Dowsett J; Ferkingstad E; Rasmussen LJH; Thørner LW; Magnússon MK; Sugden K; Thorleifsson G; Frigge M; Burgdorf KS; Ostrowski SR; Sørensen E; Erikstrup C; Pedersen OB; Hansen TF; Banasik K; Brunak S; ; Tragante V; Lund SH; Stefansdottir L; Gunnarson B; Poulton R; Arseneault L; Caspi A; Moffitt TE; Gudbjartsson D; Eugen-Olsen J; Stefánsson H; Stefánsson K; Ullum H
Commun Biol; 2021 Jun; 4(1):655. PubMed ID: 34079037
[TBL] [Abstract][Full Text] [Related]
12. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
[TBL] [Abstract][Full Text] [Related]
13. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.
Eapen DJ; Manocha P; Ghasemzadeh N; Patel RS; Al Kassem H; Hammadah M; Veledar E; Le NA; Pielak T; Thorball CW; Velegraki A; Kremastinos DT; Lerakis S; Sperling L; Quyyumi AA
J Am Heart Assoc; 2014 Oct; 3(5):e001118. PubMed ID: 25341887
[TBL] [Abstract][Full Text] [Related]
15. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
[TBL] [Abstract][Full Text] [Related]
16. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
17. Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease.
Fagerberg B; Borné Y; Barregard L; Sallsten G; Forsgard N; Hedblad B; Persson M; Engström G
Environ Res; 2017 Jan; 152():185-191. PubMed ID: 27792942
[TBL] [Abstract][Full Text] [Related]
18. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
[TBL] [Abstract][Full Text] [Related]
19. Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.
Ventorp F; Gustafsson A; Träskman-Bendz L; Westrin Å; Ljunggren L
PLoS One; 2015; 10(10):e0140052. PubMed ID: 26451727
[TBL] [Abstract][Full Text] [Related]
20. Association of Adverse Experiences and Exposure to Violence in Childhood and Adolescence With Inflammatory Burden in Young People.
Rasmussen LJH; Moffitt TE; Arseneault L; Danese A; Eugen-Olsen J; Fisher HL; Harrington H; Houts R; Matthews T; Sugden K; Williams B; Caspi A
JAMA Pediatr; 2020 Jan; 174(1):38-47. PubMed ID: 31682707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
